{"id":"W4292937262","doi":"10.1001/jamapsychiatry.2022.2096","title":"Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder","year":2022,"lang":"en","type":"letter","venue":"JAMA Psychiatry","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":657,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institutes of Health; Usona Institute; Heffter Research Institute; York University; University of Wisconsin-Madison; National Center for Advancing Translational Sciences; Purdue University","keywords":"Psilocybin; Placebo; Diphenhydramine; Alcohol use disorder; Medicine; Psychiatry; Randomized controlled trial; Hallucinogen; Relapse prevention; Psychology; Internal medicine; Alcohol","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02074578797328104,"score_gpt":0.2928198943406204,"score_spread":0.2720741063673394,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}